Genovis AB (publ.) (STO: GENO)
Sweden
· Delayed Price · Currency is SEK 24.95
-0.25 (-0.99%)
Dec 20, 2024, 5:29 PM CET
Genovis AB (publ.) Market Cap
Genovis AB (publ.) has a market cap or net worth of 1.63 billion as of December 20, 2024. Its market cap has decreased by -49.65% in one year.
Market Cap
1.63B
Enterprise Value
1.55B
Revenue
130.57M
Ranking
n/a
PE Ratio
58.52
Stock Price
24.95
Market Cap Chart
Since April 18, 2008, Genovis AB (publ.)'s market cap has increased from 7.51M to 1.63B, an increase of 21,639.04%. That is a compound annual growth rate of 38.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,196.34B |
| Swedish Orphan Biovitrum AB (publ) | 106.60B |
| Sectra AB (publ) | 52.45B |
| Getinge AB (publ) | 47.41B |
| Camurus AB (publ) | 33.14B |
| Medicover AB (publ) | 28.89B |
| Vitrolife AB (publ) | 28.16B |
| Bonesupport Holding AB (publ) | 25.03B |